公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1995 | Hemophagocytic syndrome in epstein-Barr virus-associated t-lymphoproliferative disorders: Disease spectrum, pathogenesis, and management | Su I.-J.; Wang C.-H.; ANN-LII CHENG ; Chen R.-L. | Leukemia and Lymphoma | 124 | 101 | |
2023 | Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab | CHIUN HSU ; Ducreux, Michel; Zhu, Andrew X; Qin, Shukui; Ikeda, Masafumi; Kim, Tae-You; Galle, Peter R; Finn, Richard S; Chen, Ethan; Ma, Ning; Hu, Youyou; Li, Lindong; ANN-LII CHENG | Liver cancer | 1 | 0 | |
2013 | Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group | Kim S.J.; CHIUN HSU ; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.; Lee J.; Intragumtornchai T.; Chng W.-J.; ANN-LII CHENG ; Lim S.T.; Suh C.; Kwong Y.-L.; Kim W.S. | European Journal of Cancer | 98 | 90 | |
2003 | Hepatitis B virus X protein activates a survival signaling by linking Src to phosphatidylinositol 3-kinase | Shih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG ; SHIN-LIAN DOONG | Journal of Biological Chemistry | 52 | 49 | |
2000 | Hepatitis b virus x protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway | Shih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG ; SHIN-LIAN DOONG | Journal of Biological Chemistry | 174 | 163 | |
2017 | Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells | YU-YUN SHAO ; MIN-SHU HSIEH ; Wang, Han Yu; Li, Yong Shi; Lin, Hang; Hsu, Hung Wei; Huang, Chung Yi; CHIH-HUNG HSU ; ANN-LII CHENG | Oncotarget | 12 | 9 | |
2002 | HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity | CHIUN HSU ; Huang C.-L.; Hsu H.-C.; PO-HUANG LEE ; Wang S.-J.; ANN-LII CHENG | Cancer | 41 | 33 | |
2018 | The HER2 inhibitor lapatinib potentiates doxorubicininduced cardiotoxicity through iNOS signaling | WAN-TSENG HSU ; Huang C.-Y.; Yen C.Y.T.; ANN-LII CHENG ; Hsieh P.C.H. | Theranostics | 36 | 33 | |
2011 | High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy | YU-YUN SHAO ; ZHONG-ZHE LIN ; Chen T.-J.; CHIUN HSU ; Ying-Chun Shen ; CHIH-HUNG HSU ; ANN-LII CHENG | Oncology | 17 | 17 | |
1999 | High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma | CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHONG-JEN YU ; Lin J.-F.; PAN-CHYR YANG | Cancer | 23 | | |
1998 | High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy | KUN-HUEI YEH ; CHIA-TUNG SHUN ; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG | Cancer | 105 | | |
2017 | High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma | YU-YUN SHAO ; Lin H.; Li Y.-S.; Lee Y.-H.; Chen H.-M.; ANN-LII CHENG ; CHIH-HUNG HSU | Japanese Journal of Clinical Oncology | 34 | 31 | |
2021 | High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia | LIN, CHING-HUNG ; RUBY YUN-JU HUANG ; TZU-PIN LU ; KUAN-TING KUO ; Lo, Ko-Yun; Chen, Ching-Hsuan; I-CHUN CHEN ; YEN-SHEN LU ; ERIC YAO-YU CHUANG ; Thiery, Jean Paul; CHIUN-SHENG HUANG ; ANN-LII CHENG | NPJ breast cancer | 4 | 4 | |
2015 | High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country | CHING-HUNG LIN ; Shen C.-Y.; JIH-HSIANG LEE ; CHIUN-SHENG HUANG ; CHIH-HSIN YANG ; WEN-HUNG KUO ; DWANG-YING CHANG ; Hsiung C.-N.; KUAN-TING KUO ; WEI-WU CHEN ; I-CHUN CHEN ; Wu P.-F.; SUNG-HSIN KUO ; Chen C.-J.; YEN-SHEN LU ; ANN-LII CHENG | PLoS ONE | 10 | 6 | |
2015 | High serum transforming growth factor-β1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib | Lin T.-H.; YU-YUN SHAO ; Chan S.-Y.; Huang C.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG | Clinical Cancer Research | 78 | 78 | |
1997 | High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy [2] | KUN-HUEI YEH ; ANN-LII CHENG | British Journal of Cancer | 124 | 97 | |
2003 | High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma | KUN-HUEI YEH ; YEN-SHEN LU ; Hsiao C.-H.; ANN-LII CHENG | Anticancer Research | 3 | 3 | |
1997 | High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung | KUN-HUEI YEH ; ANN-LII CHENG | Anticancer Research | 14 | 11 | |
1998 | High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers | KUN-HUEI YEH ; Lin M.-T.; Lin D.-T.; JIH-LUH TANG ; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG ; Yu S.-C.; KING-JEN CHANG ; YAO-CHANG CHEN | Breast Cancer Research and Treatment | 2 | 2 | |
2002 | High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection | JIN-TUNG LIANG ; KUO-CHIN HUANG ; HONG-SHIEE LAI ; PO-HUANG LEE ; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Wang S.-M.; Tang C.; KING-JEN CHANG | International Journal of Cancer | 109 | 98 | |